X
08Jun

FDA Signals a Deliberative Approach to Cannabis at Public Hearing

While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By: Wilson Sonsini Goodrich & Rosati
Source Url: https://www.jdsupra.com/legalnews/fda-signals-a-deliberative-approach-to-46336/

Related

Get the best person for the job, period.

I’m a long-suffering fan of the Mets and over the past two years, I’ve had to deal with the underw...

Read More >

What is a Reasonable Accommodation Under the ADA?

What is a Reasonable Accommodation Under the ADA? Under the Americans With Disabilities Act, as amen...

Read More >

Medical Board of California Releases Draft Regulations for New Physician Health and Wellness Program

In anticipation of its November Board meeting this past week, the Medical Board released its Medical...

Read More >

401(k) and 403(b) plans must be updated January 1, 2020

The IRS recently issued final regulations to standardize the administration of hardship distribution...

Read More >

The Physical and Land Use Planning Act, 2019

The new Physical and Land Use Planning Act, 2019 (the 2019 Planning Act) came into force on 5 August...

Read More >

Contracting with Disclosed Principals: Who is Your Counterparty?

It is often taken for granted that only the named parties to a contract can enforce it. The English ...

Read More >